Financhill
Back

Genpact Vs. Corcept Therapeutics Industry Stock Comparison

Sell
37

G
Genpact

Last Price:
$47.29
Seasonality Move:
4.28%
Sell
46

CORT
Corcept Therapeutics

Last Price:
$68.59
Seasonality Move:
2.94%
Sell
37
Genpact (G) is a Sell

Is Genpact a Buy, Sell or Hold?

  • The current Genpact [G] share price is $47.30. The Score for G is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
  • G is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
46
Corcept Therapeutics (CORT) is a Sell

Is Corcept Therapeutics a Buy, Sell or Hold?

  • The current Corcept Therapeutics [CORT] share price is $68.62. The Score for CORT is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
  • CORT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

G Stock Price Chart

What is Genpact's stock price today?

  • The Genpact share price today is $47.30
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and G is experiencing buying pressure, which is a positive indicator for future bullish movement.

CORT Stock Price Chart

What is Corcept Therapeutics's stock price today?

  • The Corcept Therapeutics share price today is $68.62
    The current trend is moderately bullish and CORT is experiencing buying pressure, which is a positive indicator for future bullish movement.

G Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.02 Sell
Relative Strength Index (14 RSI): 41.91 Sell
Chaikin Money Flow: 738391 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (47.77 - 50.97) Sell
Bollinger Bands (100): (44.01 - 51.47) Sell

CORT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 15.73 Buy
Relative Strength Index (14 RSI): 50.15 Buy
Chaikin Money Flow: 963031 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (51.81 - 80.17) Buy
Bollinger Bands (100): (51.04 - 70.1) Buy

G Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 47.56 Sell
20-day SMA: 49.22 Sell
50-day SMA: 50.84 Sell
200-day SMA: 42.36 Buy
8-day EMA: 47.63 Sell
20-day EMA: 48.83 Sell
50-day EMA: 49.18 Sell
200-day EMA: 44.03 Buy

CORT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 74.01 Sell
20-day SMA: 68.65 Sell
50-day SMA: 65.66 Buy
200-day SMA: 49.93 Buy
8-day EMA: 71.22 Sell
20-day EMA: 59.16 Buy
50-day EMA: 35.29 Buy
200-day EMA: 11.08 Buy

Genpact Earnings Growth & G Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.11 per share, a decrease next quarter of $0.06 per share, an increase this year of $0.31 per share, and an increase next year of $0.35 per share.

Corcept Therapeutics Earnings Growth & CORT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.22 per share, a decrease next quarter of $0.04 per share, an increase this year of $0.29 per share, and an increase next year of $1.64 per share.

Genpact Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Corcept Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):